Case 15 Flashcards
Main Drug treatment of UC
5-aminosalicylic acid (mesalazine) , corticosteroids, immunosuppressive drugs (azathioprine), anti-TNF drugs, dietary therapy, antibiotics)
Main drug treatment of Crohn’s
Corticosteroids, Immunosuppressive drugs- azathioprine, anti-Tnf, dietary therapy, antibiotics
Drug therapy for active disease in UC
Mesalazine, corticosteroid, Anti-TNF
Maintenance of remission- UC
Mesalazine, azathioprine/6-mercaptopurine, anti-TNF, vedolizumab, tofacitinib
Crohn’s active disease drug therapy
Budesonide, dietary therapy (kids) , antibiotics (perianal disease), prednisolone (systemically active corticosteroid), anti-TNF
Maintenance of remission- Crohn’s
Azathioprine, methotrexate, Anti- TNF, vedolizumab, ustekinumab
What type of drug is vedolizumab?
Gut-specific Lymphocyte traffic inhibitor. Stops the lymphocyte from trafficking inside. Blocks integrin
Anti-TNF antibodies
Infliximab, certolizumab pegol, adalimumab
General characteristics of UC
Diffuse mucosal inflammation limited to colon, affects rectum, may involve all or part of rest of colon
General aspects of Crohn’s
Patchy transmural inflammation, may affect any part of the GI tract
Symptoms of UC
Rectal Bleeding, diarrhoea, urgency, abdo pain
Extraintestinal manifestations of IBD
Aphthous stomatitis, episcleritis and uveitis, arthritis, vascular complications, e.nodosum, p.gangrenosum
Clinical patterns of Crohn’s
Inflammation, fistulization, obstruction, microperforation
Early presentations of Crohn’s
LQ pain, tenderness, diarrhea, fever, anorexia, weight loss
Endoscopic spectrum of severity in UC
Normal colon- mucosa is shy, pale pink and retains a delicate, reticulate vascular pattern
Mild- mucosa becomes duller and redder, often with a granular or fine sandpaper- like texture and vascular patter is obscured
Moderate - gross pitting of the mucosa is seen - lining may crumble away and bleed at the lightest tough - friability
Severe- macroulceration with mucopurulent exudate and spontaeous haemorrhage